Resources

In part 2 of this Exclusive Interview, Dr. Carla Greenbaum talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about predicting diabetes, the ability to test for diabetes antibiodies in very young children, and steps to treat the disease early.

In part 3 of this Exclusive Interview, Dr. Carla Greenbaum explains the reason for disease modifying therapy in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 4 of this Exclusive Interview, Dr. Carla Greenbaum talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the benefits of gene therapy and early detection even without a therapy yet in place.

In part 5 of this Exclusive Interview, Dr. Carla Greenbaum talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the importance of knowing the stages of diabetes.

In part 6 of this Exclusive Interview, Dr. Carla Greenbaum talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about what health care providers can do for people with type 1.

In part 7 of this Exclusive Interview, Dr. Carla Greenbaum talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about a diabetes vaccine and past efforts to treat those at risk.

In part 8 of this Exclusive Interview, Dr. Carla Greenbaum talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the diagnosis of diabetes in adults, as differentiated from diagnosis in children.

In part 9, the conclusion of this Exclusive Interview, Dr. Carla Greenbaum talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the realities of where diabetes research can be in the next five or more years, in relation to a cure as well as other types of treatments.

So many of my patients who have insulin resistance, type 1 or type 2 diabetes with hyperglycemia and/or obesity have vitamin D or vitamin B12 deficiency. Often they have never had their levels checked or, if they have, were diagnosed with either or both vitamin D deficiency and vitamin B12 deficiency and do not take their prescribed vitamins. Why?

In part 5 of this Exclusive Interview, Dr. Aaron Vinik talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the need to continue research into drugs such as SGLT-2s because breakthroughs may possibly be found in these medications.